University of Toronto Early-Stage Technology (UTEST) Program
Overview
University of Toronto Early-Stage Technology (UTEST) Program is a deep tech focused accelerator program that provides investment and support to research-based companies emerging from the University of Toronto.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NanoMorphix | May 2025 | Accelerator | Lead |
| Rhea Health Inc. | Oct 2021 | Seed | Co-investor |
| Ardra Inc. | Mar 2016 | Accelerator | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is University of Toronto Early-Stage Technology (UTEST) Program based?
University of Toronto Early-Stage Technology (UTEST) Program is headquartered in Toronto, Canada.
When was University of Toronto Early-Stage Technology (UTEST) Program founded?
University of Toronto Early-Stage Technology (UTEST) Program was founded in 2012.
How many portfolio companies does University of Toronto Early-Stage Technology (UTEST) Program have?
University of Toronto Early-Stage Technology (UTEST) Program has 3 portfolio companies in Caplight's dataset.
What are some companies in University of Toronto Early-Stage Technology (UTEST) Program's portfolio?
Recent investments visible on Caplight include NanoMorphix, Rhea Health Inc., Ardra Inc., Rhea Health Inc., Ardra Inc..
What was University of Toronto Early-Stage Technology (UTEST) Program's most recent investment?
University of Toronto Early-Stage Technology (UTEST) Program's most recent investment on Caplight was in NanoMorphix in 2025.
What sectors does University of Toronto Early-Stage Technology (UTEST) Program focus on?
University of Toronto Early-Stage Technology (UTEST) Program focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Energy & Sustainability, Mobility, Transportation & Logistics.
What company stages does University of Toronto Early-Stage Technology (UTEST) Program focus on?
University of Toronto Early-Stage Technology (UTEST) Program typically invests at the Early stage.